Literature DB >> 12350356

Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10.

Janis T Lee1, Gillian M Air.   

Abstract

We are interested in studying how influenza virus escapes antibody inhibition. Based on the structure of the complex between N9 NA and monoclonal antibody NC10 Fab (R. L. Malby, W. R. Tulip, V. R. Harley, J. L. McKimm-Breschkin, W. G. Laver, R. G. Webster, and P. M. Colman, 1994, Structure 2, 733-746), we investigated the contribution made by individual amino acids to the stability of the complex. We made conservative changes in residues that are centrally located in the epitope and more drastic changes in peripheral contacts. The mutations made were N200L (removing an N-linked oligosaccharide), N329Q, N345Q, S370T, S372A, N400L, and K432M. Binding of each mutant to NC10 was quantitated by NA inhibition assays and ELISA. Except for N200L and N329Q, the mutants were inhibited by NC10 to the same extent as wild-type NA although with less affinity. The enzyme activity (K(cat)) of N200L is 80% reduced, indicating a defect in folding or assembly; therefore, the loss in binding activity due to the missing sugar residue cannot be assessed. The K(d) for N329Q is sixfold higher than for wild-type NA in the inhibition test, but the same as wild-type in ELISA, indicating a change in disposition of the antibody but no loss of affinity. The results show that the NC10 epitope can accommodate a change at any site and is not dominated by a few high-energy interactions as was found in the NC41 epitope. We propose that the difference lies in the contribution of buried water molecules to the NA-NC10 complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12350356     DOI: 10.1006/viro.2002.1564

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin.

Authors:  Joshua L Cherry; David J Lipman; Anastasia Nikolskaya; Yuri I Wolf
Journal:  PLoS Curr       Date:  2009-08-18

3.  The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.

Authors:  Hongquan Wan; Jin Gao; Hua Yang; Shuang Yang; Ruth Harvey; Yao-Qing Chen; Nai-Ying Zheng; Jessie Chang; Paul J Carney; Xing Li; Ewan Plant; Lianlian Jiang; Laura Couzens; Carol Wang; Shirin Strohmeier; Wells W Wu; Rong-Fong Shen; Florian Krammer; John F Cipollo; Patrick C Wilson; James Stevens; Xiu-Feng Wan; Maryna C Eichelberger; Zhiping Ye
Journal:  Nat Microbiol       Date:  2019-08-12       Impact factor: 17.745

4.  Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6.

Authors:  Lalitha Venkatramani; Eric S Johnson; Gundurao Kolavi; Gillian M Air; Wayne J Brouillette; Blaine H M Mooers
Journal:  BMC Struct Biol       Date:  2012-05-06

Review 5.  Influenza neuraminidase.

Authors:  Gillian M Air
Journal:  Influenza Other Respir Viruses       Date:  2011-11-16       Impact factor: 4.380

6.  Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.

Authors:  Hongquan Wan; Hua Yang; David A Shore; Rebecca J Garten; Laura Couzens; Jin Gao; Lianlian Jiang; Paul J Carney; Julie Villanueva; James Stevens; Maryna C Eichelberger
Journal:  Nat Commun       Date:  2015-02-10       Impact factor: 14.919

7.  Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.

Authors:  Pramila Rijal; Bei Bei Wang; Tiong Kit Tan; Lisa Schimanski; Philipp Janesch; Tao Dong; John W McCauley; Rodney S Daniels; Alain R Townsend; Kuan-Ying A Huang
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

8.  Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin.

Authors:  Stephen J Stray; Lindsey B Pittman
Journal:  Virol J       Date:  2012-05-08       Impact factor: 4.099

Review 9.  Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.

Authors:  Nicola Clementi; Elena Criscuolo; Matteo Castelli; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

Review 10.  NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Authors:  Florian Krammer; Ron A M Fouchier; Maryna C Eichelberger; Richard J Webby; Kathryn Shaw-Saliba; Hongquan Wan; Patrick C Wilson; Richard W Compans; Ioanna Skountzou; Arnold S Monto
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.